Skip to main content
. 2017 Feb 22;7:41904. doi: 10.1038/srep41904

Figure 1. Schematic illustration of the RGD-TRAIL-ELP nanoparticle for tumor-targeted delivery.

Figure 1

Before administration, the RGD-TRAIL-ELP was heated to the temperature of 37 °C to form nanoparticles (a); RGD-TRAIL-ELP was administered by i.p (b) and deposited in tumor site (c).